# Horizon Kinetics Holding Corp: overview HKHC · OTC · CIK 88000 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/hkhc.md) · [Financials](/companies/hkhc/financials.md) · [Filings](/companies/hkhc/filings.md) · [Insiders](/companies/hkhc/insiders.md) Latest reported revenue: [$19.0m](/filings/0001193125-26-349320.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-349320). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [13.1](/filings/0001193125-25-280136.md) | [18.2 d](/filings/0001193125-26-104113.md) | [19.0](/filings/0001193125-26-225482.md) | [18.9](/filings/0001193125-26-349320.md) | [17.9](/filings/0001193125-25-280136.md) | [17.0 d](/filings/0001193125-26-104113.md) | [18.3](/filings/0001193125-26-225482.md) | [19.0](/filings/0001193125-26-349320.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(7.1%)](/filings/0001193125-25-280136.md) | [(79.0%) d](/filings/0001193125-26-104113.md) | [9.0%](/filings/0001193125-26-225482.md) | [19.4%](/filings/0001193125-26-349320.md) | [16.5%](/filings/0001193125-25-280136.md) | [16.2% d](/filings/0001193125-26-104113.md) | [(23.7%)](/filings/0001193125-26-225482.md) | [15.6%](/filings/0001193125-26-349320.md) | | Net margin | % | [(292.3%)](/filings/0001193125-25-280136.md) | [415.3% d](/filings/0001193125-26-104113.md) | [120.1%](/filings/0001193125-26-349320.md) | [(55.5%)](/filings/0001193125-26-349320.md) | [40.4%](/filings/0001193125-25-280136.md) | [(84.9%) d](/filings/0001193125-26-104113.md) | [396.5%](/filings/0001193125-26-349320.md) | [(96.5%)](/filings/0001193125-26-349320.md) | | Diluted EPS | $ per share | [(2.07)](/filings/0001193125-25-280136.md) | not reported | [1.23](/filings/0001193125-26-225482.md) | [(0.56)](/filings/0001193125-26-349320.md) | [0.39](/filings/0001193125-25-280136.md) | not reported | [3.89](/filings/0001193125-26-225482.md) | [(0.99)](/filings/0001193125-26-349320.md) | | Free cash flow | $m | not reported | [23.0 d](/filings/0001193125-26-104113.md) | [(14.5)](/filings/0001193125-26-225482.md) | [(7.8) d](/filings/0001193125-26-349320.md) | not reported | not reported | [(7.4)](/filings/0001193125-26-225482.md) | [(2.6) d](/filings/0001193125-26-349320.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [29.7](/filings/0000950170-23-010594.md) | [3.0](/filings/0000950170-24-036394.md) | [47.3](/filings/0000950170-25-047560.md) | [55.8](/filings/0001193125-26-104113.md) | [72.8](/filings/0001193125-26-104113.md) | | Gross margin | % | [42.1%](/filings/0000950170-23-010594.md) | [46.1%](/filings/0000950170-24-036394.md) | [3.1%](/filings/0000950170-24-036394.md) | not reported | not reported | | Operating margin | % | [(21.9%)](/filings/0000950170-23-010594.md) | [(332.7%)](/filings/0000950170-24-036394.md) | [(3.8%)](/filings/0000950170-25-047560.md) | [(27.0%)](/filings/0001193125-26-104113.md) | [15.2%](/filings/0001193125-26-104113.md) | | Net margin | % | [(37.3%)](/filings/0000950170-23-010594.md) | [(297.0%)](/filings/0000950170-24-036394.md) | [(9.5%)](/filings/0000950170-25-047560.md) | [165.7%](/filings/0001193125-26-104113.md) | [7.0%](/filings/0001193125-26-104113.md) | | Diluted EPS | $ per share | [(0.88)](/filings/0000950170-23-010594.md) | [(0.70)](/filings/0000950170-24-036394.md) | [(0.25)](/filings/0000950170-25-047560.md) | [5.07](/filings/0001193125-26-104113.md) | [0.27](/filings/0001193125-26-104113.md) | | Free cash flow | $m | not reported | not reported | [25.4](/filings/0000950170-25-047560.md) | [11.8](/filings/0001193125-26-104113.md) | [(43.4)](/filings/0001193125-26-104113.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hkhc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [HORIZON KINETICS ASSET MANAGEMENT LLC](/funds/1056823.md) | 2026-06-30 | $35.5m | 1,075,416 | | Unchanged | ## Recent filings [All 548 filings](/companies/hkhc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-13 | 16:30 ET | [10-Q](/filings/0001193125-26-349320.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349320 | | 2026-08-13 | 16:30 ET | [8-K](/filings/0001193125-26-349306.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349306 | | 2026-05-15 | 09:00 ET | [10-Q](/filings/0001193125-26-225482.md) | Quarterly report, period 2026-03-31 | 0001193125-26-225482 | | 2026-05-15 | 09:00 ET | [8-K](/filings/0001193125-26-225476.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-225476 | | 2026-05-11 | 06:01 ET | [8-K](/filings/0001193125-26-215560.md) | 1.01 Entry into a material agreement | 0001193125-26-215560 | | 2026-04-20 | 16:30 ET | [DEF 14A](/filings/0001193125-26-164084.md) | Proxy statement, period 2026-06-09 | 0001193125-26-164084 | | 2026-04-08 | 16:06 ET | [8-K](/filings/0001193125-26-147613.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-147613 | | 2026-03-12 | 16:06 ET | [10-K](/filings/0001193125-26-104113.md) | Annual report, period 2025-12-31 | 0001193125-26-104113 | | 2026-03-12 | 16:00 ET | [8-K](/filings/0001193125-26-104064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104064 | | 2025-11-13 | 16:06 ET | [10-Q](/filings/0001193125-25-280136.md) | Quarterly report, period 2025-09-30 | 0001193125-25-280136 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-104113.md), filed Mar 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/49b8e21c-6835-473a-a91a-9ecc78441f80) ## About the filer - CIK: 88000 - Tickers: HKHC - Exchange: OTC - SIC code: 6282 Investment Advice - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.